Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucose oxidase nasal spray in children with upper respiratory tract infections
NCT01883427Phase 2Completed
- Start
- Oct 2012
- Primary completion
- May 2013
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of glucose oxidase in upper respiratory tract infection (URI) (2 arms). Primary endpoint: Respiratory Infectious Symptoms at 3 months. Started Oct 2012; status: completed.
02
Drugs
glucose oxidase
03
Conditions
upper respiratory tract infection (URI)
Beyond the preview
Go deeper on NCT01883427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01883427.